Machine Learning
ECG Analysis
We specialize in developing AI-powered tools for analyzing ECG and other medical tests. We offer these solutions as APIs, allowing our clients to easily integrate them into their existing platforms.
At our company, we are committed to using the latest advancements in artificial intelligence to solve complex problems and drive innovation. We have a team of experienced and skilled professionals who specialize in Big Data Analytics, AI/ML, Signal Processing, and Computer Vision. We understand the unique challenges facing industries. Our team provides cutting-edge solutions based on big data analysis that help our clients make informed decisions and achieve their goals.
The advent of AI and machine learning has brought about a significant transformation in the operational processes of businesses. To keep up with the constantly evolving technology, extensive knowledge and expertise are crucial. Thus, we provide a variety of services customized to cater to the specific requirements of our clients.
Learn what projects we have done and are currently working on.
Machine Learning
We specialize in developing AI-powered tools for analyzing ECG and other medical tests. We offer these solutions as APIs, allowing our clients to easily integrate them into their existing platforms.
Data Analysis
Our consulting included providing comprehensive assistance to the client with big data projects related to pulmonary disease, where we analyze vast amounts of data to provide clients with valuable insights and results. Our support helps the client achieve their research objectives, create viable processes, and develop innovative solutions.
Signal Processing
Naiad Lab's tool meets a crucial need in the pharmaceutical industry by automating the analysis of big data from pre-clinical drug trials, reducing the time for drug discovery and decreasing reliance on manual analysis of ECG data. This efficient solution tackles a significant challenge in the industry.
Dr. Richig has over 30 years of experience in electrocardiography for preclinical safety evaluation studies and is recognized throughout the world as the leading expert in this field. He has worked or consulted for a number of pharmaceutical companies, contract research organizations and academia. In addition, Dr. Richig was appointed as a Special Government Employee (SGE) to the United States Food and Drug Administration (FDA) in the cardiovascular and renal drugs division (pre-clinical) and served for a period of 10 years. Author of the textbook: “Electrocardiography of Laboratory Animals” Second Edition, Copyright 2019.
Kar has over 20 years experience in working within multi-national pharmaceutical companies, provincial governments, and as an entrepreneur. He has driven partnerships and business development as a healthcare consultant with BioAlberta, Health City, and Asia Smart Link.
Naiad was founded in February of 2020, and since its inception it has been bootstrapped for the most part. To date, Naiad Lab has secured $180,000 CAD from Cisco Systems Canada donation, private investments, and founders contribution. The previous rounds enabled Naiad Lab to continue R&D and product-market fit activities.
Currently, we are a positive cash flow business, with numerous clients and different projects in the pipeline. Investment at this early revenue stage will enable Naiad to optimize their product, enter the pharmaceutical market and accelerate our market entry (technology adoption). Since we have achieved product market fit, this is the best time to progress our market activities and leverage our advisors for maximum revenue.
Naiad Lab is currently undergoing a bridge round.